Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CNS Disorders
>>
Sumitomo Pharma
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
3
6
9
12
15
18
21
24
27
30
ulotaront
(SEP-363856) / Otsuka, PsychoGenics
Vincerinone
(vatiquinone) / Sumitomo Pharma, PTC Therap
